Literature DB >> 30936153

Clinical Pharmacology in Diuretic Use.

David H Ellison1.   

Abstract

Keywords:  Algorithms; Cardio-Renal Syndrome; Clinical; Distal; Diuresis; Edema; Gastrointestinal Absorption; Kidney Tubules; Metabolic Networks and Pathways; Pharmacology; Sodium Potassium Chloride; Symporter Inhibitors; diuretics; heart failure; nephrotic syndrome

Year:  2019        PMID： 30936153      PMCID： PMC6682831          DOI： 10.2215/CJN.09630818

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  80 in total

1.  Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop.

Authors:  P Fernández-Llama; C A Ecelbarger; J A Ware; P Andrews; A J Lee; R Turner; S Nielsen; M A Knepper
Journal:  Am J Physiol       Date:  1999-08

2.  Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.

Authors:  Rajiv Agarwal; J Christopher Gorski; Kimberly Sundblad; D Craig Brater
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

3.  Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter.

Authors:  E Delpire; J Lu; R England; C Dull; T Thorne
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

4.  Furosemide stimulates macula densa cyclooxygenase-2 expression in rats.

Authors:  B Mann; A Hartner; B L Jensen; M Kammerl; B K Krämer; A Kurtz
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

5.  Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone.

Authors:  Joseph G Abdallah; Robert W Schrier; Charles Edelstein; Susan D Jennings; Bruce Wyse; David H Ellison
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

6.  Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.

Authors:  Haralampos J Milionis; George E Alexandrides; Evangelos N Liberopoulos; Eleni T Bairaktari; John Goudevenos; Moses S Elisaf
Journal:  Eur J Heart Fail       Date:  2002-03       Impact factor: 15.534

7.  Effect of Food on the Pharmacokinetics and Pharmacodynamics of Torsemide.

Authors:  William G. Kramer
Journal:  Am J Ther       Date:  1995-07       Impact factor: 2.688

8.  Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf.

Authors:  M Flagella; L L Clarke; M L Miller; L C Erway; R A Giannella; A Andringa; L R Gawenis; J Kramer; J J Duffy; T Doetschman; J N Lorenz; E N Yamoah; E L Cardell; G E Shull
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

9.  Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

Authors:  M D Murray; M M Deer; J A Ferguson; P R Dexter; S J Bennett; S M Perkins; F E Smith; K A Lane; L D Adams; W M Tierney; D C Brater
Journal:  Am J Med       Date:  2001-11       Impact factor: 4.965

10.  Diuretics, mortality, and nonrecovery of renal function in acute renal failure.

Authors:  Ravindra L Mehta; Maria T Pascual; Sharon Soroko; Glenn M Chertow
Journal:  JAMA       Date:  2002-11-27       Impact factor: 56.272
View more
  20 in total

1.  Body fluid regulation via chronic inhibition of sodium-glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial.

Authors:  Shinya Fujiki; Atsushi Tanaka; Takumi Imai; Michio Shimabukuro; Hiroki Uehara; Ikuko Nakamura; Kazuo Matsunaga; Makoto Suzuki; Takeshi Kashimura; Tohru Minamino; Takayuki Inomata; Koichi Node
Journal:  Clin Res Cardiol       Date:  2022-06-22       Impact factor: 5.460

Review 2.  The role of furosemide and fluid management for a hemodynamically significant patent ductus arteriosus in premature infants.

Authors:  Sarah Dudley; Shawn Sen; Alison Hanson; Afif El Khuffash; Philip T Levy
Journal:  J Perinatol       Date:  2022-07-15       Impact factor: 3.225

3.  Nephrotic Syndrome Complications - New and Old. Part 1.

Authors:  Ruxandra Mihaela Busuioc; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-03

Review 4.  Revisiting diuretic choice in chronic kidney disease.

Authors:  Sehrish Ali; Sankar D Navaneethan; Salim S Virani; L Parker Gregg
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-07-11       Impact factor: 3.416

Review 5.  Diuretics and the kidney.

Authors:  R Bell; R Mandalia
Journal:  BJA Educ       Date:  2022-04-20

6.  Can fractional excretion of sodium predict worsening of renal function, in-hospital mortality, and length of hospital stay in acute decompensated heart failure?

Authors:  Farzaneh Ahmadi; Ekhlas Torfi; Sayed Mohammadreza Afshani; Saadat Kazemi-Mansourabad; Fatemeh Hayati
Journal:  ARYA Atheroscler       Date:  2021-11

Review 7.  Metabolic Alkalosis: A Brief Pathophysiologic Review.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-25       Impact factor: 8.237

8.  Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?

Authors:  Sadiya S Khan; Mark D Huffman; Sanjiv J Shah
Journal:  Circ Heart Fail       Date:  2021-03-05       Impact factor: 8.790

9.  Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study).

Authors:  Isao Sakaida; Shuji Terai; Masayuki Kurosaki; Mitsuru Okada; Takahiro Hirano; Yasuhiko Fukuta
Journal:  J Gastroenterol       Date:  2020-05-09       Impact factor: 7.527

10.  The Effects of Furosemide on Behavioral and Hormonal Parameters in Male and Female Mice Subjected to Immobilization and Cold-Water Stress.

Authors:  Mohammed Al Za'abi; Badreldin H Ali; Yousuf Al Suleimani; Ibrahim Al-Zakwani; Balqees Al-Fulaiti; Priyadarsini Manoj; Abderrahim Nemmar
Journal:  J Exp Pharmacol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.